Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

Preparation and Characterization of Simvastatin Solid Dispersion using Aqueous Solvent

  • Received : 2011.06.16
  • Accepted : 2011.08.11
  • Published : 2011.08.20
Download PDF
⟨ Previous Next ⟩

Abstract

Simvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, which catalyzes the conversion of HMG-CoA to mevalonate, an early and rate-limiting step in the biosynthesis of cholesterol. Simvastatin has good permeability, but it also has low solubility (BCS class II), which reduces its bioavailability. To overcome this problem, a solid dispersion is formed using a spray-dryer with polymeric material carrier to potentially enhance the dissolution rate and extend drug absorption. As carriers for solid dispersion, Gelucire$^{(R)}$44/14 and Gelucire$^{(R)}$ 50/13 are semisolid excipients that greatly improve the bioavailability of poorly-soluble drugs. To avoid any toxic effects of an organic solvent, we used aqueous medium to melt Tween$^{(R)}$ 80 and distilled water. The structural behaviors of the raw materials and the solid dispersion were analyzed by differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD) and scanning electron microscopy (SEM). The DSC and PXRD data indicated that the crystalline structure of simvastatin was transformed to an amorphous structure through solid dispersion. Then, solid dispersion-based tablets containing 20 mg simvastatin were prepared with excipients. Dissolution tests were performed in distilled water and artificial intestinal fluid using the USP paddle II method. Compared with that of the commercial tablet (Zocor$^{(R)}$ 20 mg), the release of simvastatin from solid dispersion based-tablet was more efficient. Although the stability study is not complete, this solid dispersion system is expected to deliver poorly water-soluble drugs with enhanced bioavailability and less toxicity.

Keywords

References

  1. Ahn, Y.S., Lee, H.Y., Hong, K.D., Jung, S.B., Cho, S.H., Rhee, J.M., Lee, H.B., Khang, G., 2004. Effect of types and mixing ratios of water-soluble polymers on in vitro release profile of solid dispersion for acyclovir, J. Kor. Pharm. Sci., 34(4), 289-297.
  2. Ahn, Y.S., Lee, H.Y., Hong, K.D., Jung, S.B., Cho, S.H., Rhee, J.M., Lee, H.B., Khang, G., 2004. Preparation and in vitro test of solid dispersion using acyclovir and water soluble polymer, J. Korean Pharm. Sci., 34(3), 169-176.
  3. Aiaraksinen, S., Karjalainen, M., Kivikero, N., Westermarck, S., Shevchenko, A., 2005. Excipient selection can significantly affect solic-state phase transformation in formulation during wet granulation. AAPS Pharm Sci Tech. 41, 311-322.
  4. Anna, K., Nissim, G., 2006. Microemulsions as transdermal drug delivery vehicles. Adv. Colloid Interface Sci., 123-126, 369-385. https://doi.org/10.1016/j.cis.2006.05.014
  5. Bates, T.R., 1969. Dissolution characteristics of reserpine-polyvinylpyrrolidone co-precipitates, J. Pharm. Pharmacol., 21, 710-712. https://doi.org/10.1111/j.2042-7158.1969.tb08159.x
  6. Betageri, G.V., Makarla, K.R., 1995. Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques, Int. J. Pharm., 126, 155-160. https://doi.org/10.1016/0378-5173(95)04114-1
  7. Brandari, K.H., Newa, M., Kim, J.A., Yoo, B.K., Woo, J.S., Lyoo, W.S., Lim, H.T., Choi, H.G., Yong, C.S., 2007. Preparation, characterization and evaluation of coenzyme Q10 binary solid dispersions for enhanced solubility and dissolution, Biol. Pharm. Bull., 30(6), 1171-1176. https://doi.org/10.1248/bpb.30.1171
  8. Bullen, W.W., Miller, R.A., Hayes, R.N., 1999. Development and validation of a high performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasma, J. Am. Soc. Mass Spectrum., 10, 55-66. https://doi.org/10.1016/S1044-0305(98)00118-4
  9. Chae, G.S., Lee, J.S., Kim, S.H., Jeong, S.Y., Kim, M.S., Cho, S.H., Lee, H.B., Khang, G., 2002. Enhancement of the stability of BCNU using self-emulsifying drug delivery systems (SMEDDS) and in vitro antitumor activity of self-emulsified BCNU-loaded PLGA wafer, Int. J. Pharm., 231, 311-144.
  10. Chiou, W.L., Riegelman, J.L., 1971. Pharmaceutical application of solid dispersion system, J. Pharm. Sci., 60, 1281-1301. https://doi.org/10.1002/jps.2600600902
  11. Chiou, W.L., Riegelman, S., 1969. Preparation and dissolution charateristics of several fast-release solid dispersions of griseofulvin, J. Pharm. Sci., 58, 1505-1510. https://doi.org/10.1002/jps.2600581218
  12. Craig, D.Q.M., 2002. The mechanism of drug release from solid dispersion in water-soluble polymers. Int, J, Pharm., 231, 131-144. https://doi.org/10.1016/S0378-5173(01)00891-2
  13. De Angelis, G., 2004. The influence of statin characteristics on their safety and tolerability. Int. J. Clin. Pract., 58, 945-955. https://doi.org/10.1111/j.1368-5031.2004.00355.x
  14. El-Zein, H., Riad, L., Elbary, A.A., 1998. Enhancement of carbamazepine dissolution - in vitro and in vivo evaluation, Int. J. Pharm., 168, 209-220. https://doi.org/10.1016/S0378-5173(98)00093-3
  15. FDA, Center for Drug Evaluation and Research 2000. Guidance for Industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system.
  16. Fini, A., Moyano, J.R., Gines, J.M., Perez-Martinez, J.I., Rabasco, A.M., 2005. Diclofenac salts, II. solid dispersions in PEG6000 and Gelucire 50/13, Eur. J. Pharm. Biopharm., 60, 99-111. https://doi.org/10.1016/j.ejpb.2004.11.005
  17. Jeong, J.K., Kim, J.H., Khang, G., Rhee, J.M., Lee, H.B., 2002. Preparation and characterization of solid dispersion of ipriflavone with polyvinylpyrrolidone, J. Korean Pharm. Sci., 32(3), 173-179. https://doi.org/10.4333/KPS.2002.32.3.173
  18. Maggon, K., 2005. Best selling human medicines, Drug discovery Today, 10(11), 739-42. https://doi.org/10.1016/S1359-6446(05)03468-9
  19. Kang, B.K., Lee, J.S., Chon, S.K., Jeung, S.Y., Yuk, S.H., Khang, G., Lee, H.B., Cho, S.H., 2004. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs, Int. J. Pharm., 274, 65-73. https://doi.org/10.1016/j.ijpharm.2003.12.028
  20. Kang, B.K., Yoon, B.Y., Seo, K.S., Jeung, S.Y., Kil, H.J., Khang, G., Lee, H.B., Cho, S.H., 2003. Preparation of solid dosage form containing SMEDDS of simvastatin by micro encapsulation, J. Kor. Pharm. Sci., 33(2), 121-127.
  21. Kanig, J.L., 1964. Properties of fused mannitol in compressed tablets, J. Pharm. Sci., 53, 188-192. https://doi.org/10.1002/jps.2600530217
  22. Khang, G., Jeong, J.K., Rhee, J.M., Lee, H.B., 2001. Effect of hydrophilic polymers on solid dispersions of ipriflavone to improve bioavailability, Macromol. Chem. Symp., 14(3), 123-132.
  23. Kim, M.S., Jin, S.J., Kim, J.S., Park, H.J., Song, H.S., Neubert, R.H.H., Hwang, S.J., 2008. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process, Eur. J. Pharm. Biopharm., in press.
  24. Kearney, A.S., Gabriel, D.L., Mehta, S.C., Radebaugh, G.W., 1994. Effect of polyvinylpyrrolidone on the crystallinity and dissolution rate of solid dispersions of the antiinflammatory Ci-987, Int. J. Pharm., 104, 169-174. https://doi.org/10.1016/0378-5173(94)90192-9
  25. Koh, K.K., Quon, M.J., Rosenson, R.S., Chung, W.J., Han, S.H., 2008. Vascular and metabolic effects of treatment of combined hyperlipidemia : Focus on statins and fibrates, Int. J. Cardiol., 124, 149-159.
  26. Lee, J.H., Kim, D.S., Kim, W., Park, J.H., Ahn, S.I., Kim, Y.T., Rhee, J.M., Khang, G., 2008. Improved dissolution of solid dispersed atorvastatin using spray-dryer, J. Kor. Pharm. Sci., 38(4), 249-254. https://doi.org/10.4333/KPS.2008.38.4.249
  27. Lee, J.H., Ku, J., Park, J.S., Park, J.H., Ahn, S.I., Mo, J.H., Kim, Y.T., Rhee, J.M., Lee, H.B., Khang, G., 2008. Improved dissolution and characterization of solid dispersed atorvastatin calcium, J. Kor. Pharm. Sci., 38(2), 111-117. https://doi.org/10.4333/KPS.2008.38.2.111
  28. Lee, J.W., 2006. The root of ambulatory care, Korea Med Pub, 16-21.
  29. Leuner, C., Dressman, J., 2000. Improving drug solubility for oral delivery using solid dispersions (review article), Eur. J. Pharm. Biopharm., 50, 47-60. https://doi.org/10.1016/S0939-6411(00)00076-X
  30. Lindenberg, M., Kopp, S., Dressman, J.B., 2004. Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system, Eur. J. Pharm. Biopharm., 58, 265-278. https://doi.org/10.1016/j.ejpb.2004.03.001
  31. Lo, W.Y., Law, S.L., 1996. Dissolution behavior of griseofulvin solid dispersions using polyethylene glycol, talc, and their combination as dispersion carriers, Drug Dev. Ind. Pharm., 22, 231-236. https://doi.org/10.3109/03639049609058566
  32. Mayersohn, M., Gibaldi, M., 1966. New method of solid-state dispersion for increasing dissolution rates, J. Pharm. Sci., 55, 1323-1324. https://doi.org/10.1002/jps.2600551138
  33. Noyes, A.A., Whitney, W.R., 1897. J. Am. Chem. Soc., 19, 930-934. https://doi.org/10.1021/ja02086a003
  34. Ohara, T., Kitamura, S., Kitagawa, T., Terada, K., 2005. Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose, Int. J. Pharm., 302, 95-102. https://doi.org/10.1016/j.ijpharm.2005.06.019
  35. Oh, H.Y., 2004. Hyperlipidemia. in Handbook of Internal Medicine, 2nd ed., pp. 440-446.
  36. Ro, H.S., Ko, W., Yang, H.O., Park, K.K., Cho, Y.H., Park, H.S., 1997. Effect of several solvent extracts from paeoniae radix on experimental hyperlipidemia in rats, J. Kor. Pharm. Sci., 27(2), 145-151.
  37. Sah, H.K., Lee, K.S., Beak, M.S., 2006. Implementation of biopharmaceutics classification system concepts in developing dissolution tests, J. Kor. Pharm. Sci., 36(3), 161-167. https://doi.org/10.4333/KPS.2006.36.3.161
  38. Sekiguchi, K., Obi, N., 1961. Studies on absorption of eutectic mixture. I. A comparison of the behavior of eutectic mixtures of sulphathiazole and that of ordinary sulphathiazole in man, Chem. Pharm. Bull., 9, 866-872. https://doi.org/10.1248/cpb.9.866
  39. Sekiguchi, K., Obi, N., Ueda, Y., 1964. Studies on absorption of eutectic mixtures. I. Absorption of fused conglomerates of chloramphenicol and urea in rabbits, Chem. Pharm. Bull., 12, 134-144. https://doi.org/10.1248/cpb.12.134
  40. Shibata, Y., Fujii, M., Sugamura, Y., Yoshikawa, R., Fujimoto, S., Nakanishi, S., Motosugi, Y., Koizumi, N., Yamada, M., Ouchi, K., Watanabe, Y., 2009. The preparation of a solid dispersion powder of indomethacin with crospovidone using a twinscrew extruder or kneader, Int. J. Pharm., 365, 53-60. https://doi.org/10.1016/j.ijpharm.2008.08.023
  41. Storda, D., Kontoyannis, C.G., 2008. Identification and quantitative determination of atorvastatin calcium polymorph in tablets using FT-Raman spectroscopy, Talanta, 74, 1066-1070.
  42. Tachibana, T., Nakamura A., 1965. A method for preparing an aqueous colloidal dispersion of organic materials by using water-soluble polymers : dispersion of beta-carotene by polyvinylpyrrolidone, Kolloid-Z. Polym., 203, 130-133. https://doi.org/10.1007/BF01507758
  43. Tran, P.H.L., Tran, H.T.T., Lee, B.J., 2008. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlles release, J. Controlled Release., 129, 59-65. https://doi.org/10.1016/j.jconrel.2008.04.001
  44. Vilhelmsen, T., Eliasen, H., Schaefer, T., 2005. Effect of a melt agglomeration process on agglomerates containing solid dispersions, Int. J. Pharm., 303, 132-142. https://doi.org/10.1016/j.ijpharm.2005.07.012
  45. Yalkowsky, S.H., 1981. Techniques of Solubilization of Drugs, Marcel Dekker, Inc., pp. 15-157.
  46. Yuksel, N., Karatas, A., Ozkan, Y., Savaser, A., Ozkan, S.A., Baykara, T., 2003. Enhanced bioavailability of piroxicam using Gelucire 44/14 and labrasol : in vitro and in vivo evaluation, Eur. J. Pharm. Biopharm., 56, 453-459. https://doi.org/10.1016/S0939-6411(03)00142-5

Cited by

  1. Effects of absorbent materials on a self-emulsifying drug delivery system for a poorly water soluble drug vol.45, pp.6, 2015, https://doi.org/10.1007/s40005-015-0201-4